Related Experiment Video
Updated: Aug 11, 2026
07:40
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
The development of a computerized LAN-based investigational drug information database
L K Gajewski1, G J Vanscoy, J C Dean
1Univerity of Pittsburgh School of Pharmacy, USA.
Hospital Pharmacy
|December 1, 1995
Summary
A new database, IRxBase, improves access to investigational drug information for healthcare professionals. This system addresses the lack of protocol-specific data, enhancing drug research accessibility and confidentiality.
Area of Science:
- Health Informatics
- Clinical Pharmacology
- Drug Development
Background:
- Healthcare professionals faced challenges accessing systematic, protocol-specific investigational drug information.
- Existing commercial software offered limited and non-specific investigational drug data.
- A need existed for a centralized, accessible platform for investigational drug details.
Purpose of the Study:
- To develop and implement IRxBase, a LAN-based database for investigational drug information.
- To enhance healthcare professionals' access to critical, protocol-specific drug data.
- To address limitations of existing investigational drug information systems.
Main Methods:
- A survey was conducted among healthcare professionals to identify information access problems.
- A computerized, Local Area Network (LAN)-based database (IRxBase) was developed.
- The database was designed for accessibility, ongoing data entry, and confidentiality.
Main Results:
- IRxBase was developed to centralize and streamline access to investigational drug information.
- The system provides protocol-specific data, overcoming limitations of previous methods.
- Key advantages include improved accessibility, continuous data updates, and maintained confidentiality.
Conclusions:
- IRxBase provides an efficient solution for disseminating investigational drug information.
- The database enhances the systematic provision of protocol-specific drug data.
- IRxBase improves data accessibility and management for healthcare professionals involved in drug research.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
14:34A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Related Concept Videos
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:20Drug Product Performance: In Vitro–In Vivo Correlation
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...